STOCKHOLM, Jan. 17 (Xinhua) -- Sweden continues to buy and use the antiviral drug remdesivir to treat COVID-19 patients, despite the World Health Organization (WHO)'s advice against doing do, Swedish News Agency TT reported on Sunday.
"We believe that there is still a place for remdesivir," Charlotta Bergquist, group manager and vaccine coordinator at the Swedish Medical Products Agency, told TT, explaining that the drug could help reduce hospital care time for a specific patient group.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!